Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat - Reuters

As reported by Reuters

Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat Reuters

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Reuters ↗

Market Samachar is a news aggregator. This article was originally published by Reuters. Tap the button above to read the full story on their site.

COMPANIES 100 days of Iran war, Rs 4,50,000 crore wiped out: Is your stock portfolio safe from missiles? Stocks-Markets-Economic Times
COMPANIES Kospi ends 8% lower as chip rout deepens; Samsung, SK Hynix crash up to 10% Stocks-Markets-Economic Times
INDIAN Penny stock under ₹10 hits upper circuit despite stock market sell-off mint - markets
INDIAN Carlsberg plans to file for $700-million India IPO in June, listing likely in 2026 mint - markets
INDIAN TCS, Wipro to Infosys: IT stocks bleed on AI and tech stocks selloff in global markets; Nifty IT dips 2% mint - markets
INDIAN Adani Ports shares in focus as company bags 10-year marine services contract for Argentina's first LNG export project mint - markets
CRYPTO Arthur Hayes dumps WLD days after Maelstrom’s AI IPO pitch Cointelegraph.com News
CRYPTO Galaxy drops CLARITY Act odds to 60% as time is running out Cointelegraph.com News

Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat - Reuters

More from Market Samachar